Research programme: somatostatin receptor agonists - Crinetics Pharmaceuticals
Latest Information Update: 05 Nov 2015
At a glance
- Originator Crinetics Pharmaceuticals
- Class Small molecules
- Mechanism of Action Somatostatin receptor 2 agonists; Somatostatin receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Acromegaly; Neuroendocrine tumours
Most Recent Events
- 05 Nov 2015 Early research in Acromegaly in USA (PO)
- 05 Nov 2015 Early research in Neuroendocrine tumours in USA (PO)